ATE98644T1 - 3-beta-(3,4-disubstituiertes succinimido)azetidinone. - Google Patents

3-beta-(3,4-disubstituiertes succinimido)azetidinone.

Info

Publication number
ATE98644T1
ATE98644T1 AT87306089T AT87306089T ATE98644T1 AT E98644 T1 ATE98644 T1 AT E98644T1 AT 87306089 T AT87306089 T AT 87306089T AT 87306089 T AT87306089 T AT 87306089T AT E98644 T1 ATE98644 T1 AT E98644T1
Authority
AT
Austria
Prior art keywords
disubstituted
beta
azetidinones
succinimido
chiral
Prior art date
Application number
AT87306089T
Other languages
English (en)
Inventor
Robin David Grey Cooper
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE98644T1 publication Critical patent/ATE98644T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
AT87306089T 1986-07-10 1987-07-09 3-beta-(3,4-disubstituiertes succinimido)azetidinone. ATE98644T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/884,124 US4734498A (en) 1986-07-10 1986-07-10 3β-succinimidoazetidinones as chiral intermediates
EP87306089A EP0252744B1 (de) 1986-07-10 1987-07-09 3-Beta-(3,4-disubstituiertes succinimido)azetidinone

Publications (1)

Publication Number Publication Date
ATE98644T1 true ATE98644T1 (de) 1994-01-15

Family

ID=25384007

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87306089T ATE98644T1 (de) 1986-07-10 1987-07-09 3-beta-(3,4-disubstituiertes succinimido)azetidinone.

Country Status (11)

Country Link
US (1) US4734498A (de)
EP (1) EP0252744B1 (de)
JP (1) JP2510600B2 (de)
KR (1) KR950013767B1 (de)
AT (1) ATE98644T1 (de)
CA (1) CA1320209C (de)
DE (1) DE3788463T2 (de)
ES (1) ES2061503T3 (de)
HU (1) HU197896B (de)
IE (1) IE61494B1 (de)
IL (1) IL83121A (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0715235Y2 (ja) * 1989-01-31 1995-04-10 鐘淵化学工業株式会社 画像読み取り装置に於けるセンサ素子の位置決め装置
US5225553A (en) * 1990-09-13 1993-07-06 Eli Lilly And Company Intermediates to 1-carbacephalosporins and process for preparation thereof
DE69131826T2 (de) * 1990-09-13 2000-05-25 Eli Lilly And Co., Indianapolis Zwischenprodukte für 1-Carbacephalosporin und Verfahren zur Herstellung dieser
US5159073A (en) * 1990-09-13 1992-10-27 Eli Lilly And Company Intermediates to 1-carbacephalosporins and process for preparation thereof
US5175256A (en) * 1990-09-28 1992-12-29 Neorx Corporation Protein labeling reagents
US5599336A (en) * 1992-07-02 1997-02-04 The Procter & Gamble Company Absorbent hydrogel fines in absorbent structures
EP0939632B1 (de) 1996-02-23 2005-10-05 Eli Lilly And Company Non-peptidische vasopressin via antagonisten
JP2000247934A (ja) * 1999-02-23 2000-09-12 Toray Ind Inc 高光学純度アミノ酸ベンジルエステルの製造法
US6706916B1 (en) 1999-02-23 2004-03-16 Toray Fine Chemicals Co., Ltd. Optically active amino acid derivatives and processes for the preparation of the same
JP4524841B2 (ja) * 1999-03-02 2010-08-18 東レ・ファインケミカル株式会社 光学活性アミノ酸エステル酒石酸アミドおよびその製造法
ES2666188T3 (es) * 2001-10-12 2018-05-03 Azevan Pharmaceuticals, Inc. Antagonistas del v1a de vasopresina beta-lactámicos
EP1868434A4 (de) 2005-03-22 2011-10-26 Azevan Pharmaceuticals Inc Beta-lactamylalkansäuren zur behandlung von prämenstruellen störungen
KR101523776B1 (ko) 2005-07-19 2015-05-28 아제반 파마슈티칼스, 인코퍼레이티드 베타-락타민 페닐알라닌, 시스테인 그리고 세린 바소프레신길항물질
US20100016274A1 (en) * 2006-09-14 2010-01-21 Koppel Gary A Beta-lactam cannabinoid receptor modulators
KR100932221B1 (ko) * 2007-11-07 2009-12-16 강원대학교산학협력단 베타락탐 올리고머 및 이의 제조방법
PL2587919T3 (pl) 2010-07-01 2018-05-30 Azevan Pharmaceuticals, Inc. Sposoby leczenia zespołu stresu pourazowego
NZ724718A (en) 2014-03-28 2023-04-28 Azevan Pharmaceuticals Inc Compositions and methods for treating neurodegenerative diseases
CA3075759A1 (en) 2017-09-15 2019-03-21 Azevan Pharmaceuticals, Inc. Compositions and methods for treating brain injury

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665171A (en) * 1985-07-17 1987-05-12 Harvard University Process and intermediates for β-lactam antibiotics

Also Published As

Publication number Publication date
HUT44536A (en) 1988-03-28
IL83121A (en) 1992-09-06
HU197896B (en) 1989-06-28
IE871841L (en) 1988-01-10
DE3788463D1 (de) 1994-01-27
KR950013767B1 (ko) 1995-11-15
CA1320209C (en) 1993-07-13
JP2510600B2 (ja) 1996-06-26
EP0252744B1 (de) 1993-12-15
ES2061503T3 (es) 1994-12-16
EP0252744A2 (de) 1988-01-13
US4734498A (en) 1988-03-29
EP0252744A3 (en) 1989-12-13
JPS6323858A (ja) 1988-02-01
IE61494B1 (en) 1994-11-02
KR880001638A (ko) 1988-04-25
DE3788463T2 (de) 1994-04-28

Similar Documents

Publication Publication Date Title
ATE98644T1 (de) 3-beta-(3,4-disubstituiertes succinimido)azetidinone.
DE3587546D1 (de) Verfahren zur Herstellung von optisch aktiven Acyloxyazetidinonen.
IE861900L (en) INTERMEDIATES FOR ß-LACTAM ANTIBIOTICS
DE3782785D1 (de) Piperidinderivate, ihre herstellung und ihre verwendung.
FI870138A0 (fi) Ymp av graott gjutjaern.
DE3787333D1 (de) Zwischenprodukte für Antibiotika.
DE68903405D1 (de) Verfahren zur herstellung von 2-alpha-methyl-2-beta-(1,2,3-triazol-1-yl)methylpenam-3-alpha-carbonsaeurederivaten.
GB8500831D0 (en) Preparing azetidinone intermediates
DE3750496D1 (de) N-(substituiertes-1-Piperazinalkyl)-alpha-(3,5-dialkyl-4-hydroxyphenyl)-alpha,alpha-dialkylacetamide.
DK557687D0 (da) Fremgangsmaade til fremstilling af en azetidinonforbindelse
DE69427100D1 (de) Herstellung von Beta-lactamverbindungen und Zwischenprodukte
ATE188211T1 (de) Cyclopropyl-derivate, verfahren zur herstellung und anwendungen
IL91932A0 (en) Azetidinone intermediates to carbacephalosporins and process
ATE159246T1 (de) Verfahren zur herstellung von (s)-vinyl- und (s)- allenyl-gaba
ATE35982T1 (de) Azetidinderivate.
AU621749B2 (en) Process for synthesizing beta-lactam compounds
ATE109771T1 (de) Verfahren zur herstellung von azetidinonen.
ATE76065T1 (de) Herstellung von azetidinonen und zwischenprodukten.
BR8600523A (pt) Compostos de carboxilatos de azetidiona substituida,processo para sua preparacao e processo para preparacao de uma 3-hidroximetil azetidina n-substituida
FI923615A (fi) Substituoituja N3-tioasyylisemikarbatsideja

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee